SCHEMBL8911780

SCHEMBL8911780

O=c1ccc2ccc3ncccc3c2nn1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.62
MAPT P10636 3/20 0.50
CYP3A4 P08684 3/20 0.50
KDM4E B2RXH2 3/20 0.50
NCOA1 Q15788 2/20 0.41
HSP90AA1 P07900 3/20 0.41
HTT P42858 2/20 0.41
HIF1A Q16665 2/20 0.41
TSHR P16473 2/20 0.41
GMNN O75496 1/20 0.41
TP53 P04637 1/20 0.41
MMP2 P08253 1/20 0.41
CYP2D6 P10635 1/20 0.41
MMP9 P14780 1/20 0.41
ALOX15 P16050 1/20 0.41
NFKB1 P19838 1/20 0.41
MMP8 P22894 1/20 0.41
CCR1 P32246 1/20 0.41
THPO P40225 1/20 0.41
MTOR P42345 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7610124 0.82 LMNA (0.61) LMNAMAPTCYP3A4KDM4ENCOA1
SCHEMBL7433014 0.81 LMNA (0.70) LMNAMAPTCYP3A4KDM4ENCOA1
SCHEMBL710195 0.79 LMNA (0.67) LMNAMAPTCYP3A4KDM4ENCOA1
SCHEMBL2361740 0.78 LMNA (0.60) LMNAMAPTCYP3A4KDM4ENCOA1
SCHEMBL6513577 0.77 LMNA (1.00) LMNAMAPTCYP3A4KDM4EHSP90AA1
SCHEMBL8313 0.77 LMNA (1.00) LMNAMAPTCYP3A4KDM4EHSP90AA1
SCHEMBL28527433 0.77 LMNA (0.89) LMNAMAPTCYP3A4KDM4EHSP90AA1
Benzoquinone SCHEMBL1512993 0.76 LMNA (0.79) LMNAMAPTCYP3A4KDM4ENCOA1
SCHEMBL723791 0.76 LMNA (0.96) LMNAMAPTCYP3A4KDM4EHSP90AA1
Iodide SCHEMBL10638043 0.76 LMNA (0.96) LMNAMAPTCYP3A4KDM4EHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0085899-B1 PYRIDOBENZODIAZEPINONES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Dr. Karl Thomae GmbH (DE) 1986-10-29 EP claimed
EP-0085893-B1 PYRIDOBENZODIAZEPINONES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Dr. Karl Thomae GmbH (DE) 1986-05-14 EP claimed
EP-0085899-A2 Pyridobenzodiazepinones, process for their preparation and pharmaceutical compositions containing them Dr. Karl Thomae GmbH (DE) 1983-08-17 EP claimed
EP-0085893-A2 Pyridobenzodiazepinones, process for their preparation and pharmaceutical compositions containing them Dr. Karl Thomae GmbH (DE) 1983-08-17 EP claimed
EP-1606268-B1 5,10-DIHYDRO-11H-DIBENZO[B,E][1,4]DIAZEPIN-11-ONE AS KINASE INHIBITORS ABBVIE INC (US) 2015-05-20 EP disclosed
US-5593979-A TREATMENT OF AIDS WITH ENZYME INHIBITORS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1997-01-14 US disclosed
EP-0330756-B1 Thienotricyclics for the treatment of bronchial diseases BYK GULDEN LOMBERG CHEM FAB (DE) 1996-03-27 EP disclosed
EP-0556947-A1 Use of M1-selective antimuscarinic pyridobenzodiazepinones for the treatment and prevention of axial myopia MERCK & CO. INC. (US) 1993-08-25 EP disclosed
EP-0556947-A1 Use of M1-selective antimuscarinic pyridobenzodiazepinones for the treatment and prevention of axial myopia MERCK & CO. INC. (US) 1993-08-25 EP disclosed
EP-0556947-A1 Use of M1-selective antimuscarinic pyridobenzodiazepinones for the treatment and prevention of axial myopia MERCK & CO. INC. (US) 1993-08-25 EP disclosed
WO-1993013777-A1 METHOD OF USING M1-SELECTIVE ANTIMUSCARINIC PYRIDOBENZODIAZEPINONES IN AXIAL MYOPIA THERAPY MERCK & CO., INC. (US) 1993-07-22 WO disclosed
WO-1993013777-A1 METHOD OF USING M1-SELECTIVE ANTIMUSCARINIC PYRIDOBENZODIAZEPINONES IN AXIAL MYOPIA THERAPY MERCK & CO., INC. (US) 1993-07-22 WO disclosed
WO-1981000568-A1 BENZODIAZEPINONES,A PROCESS FOR THEIR PREPARATION,THEIR USE AND MEDICAMENTS CONTAINING THEM BYK GULDEN LOMBERG CHEM FAB (DE) 1981-03-05 WO disclosed
US-4213984-A ANTIULCER AGENTS, ANTISECRETORY AGENTS BOEHRINGER INGELHEIM GMBH (DE) 1980-07-22 US disclosed
US-4210648-A ANTIULCEROGENICS, SECRETION INHIBITORS BOEHRINGER INGELHEIM GMBH (DE) 1980-07-01 US disclosed
US-4167570-A BRONCHOSPASMOLYTICS, BRONCHOSECRETOLYTICS BOEHRINGER INGELHEIM GMBH (DE) 1979-09-11 US disclosed
US-4154833-A INDOMETHACIN (1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYL-1H-INDOLE-3-ACETIC ACID) WITH PIRENZEPINE (5,11-DIHYDRO-11-((4-METHYL-1-PIPERAZINYL)-ACETYL)-6H-PYRIDO(2,3 -B)(1,4)BENZODIAZEPIN-6-ONE) BOEHRINGER INGELHEIM GMBH (DE) 1979-05-15 US disclosed
US-4154833-A INDOMETHACIN (1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYL-1H-INDOLE-3-ACETIC ACID) WITH PIRENZEPINE (5,11-DIHYDRO-11-((4-METHYL-1-PIPERAZINYL)-ACETYL)-6H-PYRIDO(2,3 -B)(1,4)BENZODIAZEPIN-6-ONE) BOEHRINGER INGELHEIM GMBH (DE) 1979-05-15 US disclosed
US-4021557-A BRONCHOSPASMOLYTICS BOEHRINGER INGELHEIM GMBH (DT) 1977-05-03 US disclosed
US-3987197-A ANTIRHEUMATICS AND ANTIPHLOGISTICS BOEHRINGER INGELHEIM GMBH (DT) 1976-10-19 US disclosed